Results 281 to 290 of about 1,594,150 (301)
Some of the next articles are maybe not open access.
Nihon rinsho. Japanese journal of clinical medicine, 2002
T, Ohara, M, Kasuga
openaire +1 more source
T, Ohara, M, Kasuga
openaire +1 more source
Managing diabetes with nanomedicine: challenges and opportunities
Nature Reviews Drug Discovery, 2014Omid Veiseh +2 more
exaly
2007
Type 2 diabetes mellitus comprises a group of common metabolic disorders that the phenotype of hyperglycaemia. Hyperglycaemia may include reduced insulin secretion, decreased glucose utilization and increased glucose production. The metabolic dysreguiation associated with type 2 diabetes mellitus causes secondary pathophysiologic changes in multipl ...
openaire +1 more source
Type 2 diabetes mellitus comprises a group of common metabolic disorders that the phenotype of hyperglycaemia. Hyperglycaemia may include reduced insulin secretion, decreased glucose utilization and increased glucose production. The metabolic dysreguiation associated with type 2 diabetes mellitus causes secondary pathophysiologic changes in multipl ...
openaire +1 more source
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
New England Journal of Medicine, 2015Bernard Zinman Cm +2 more
exaly
Engineering immunomodulatory biomaterials for type 1 diabetes
Nature Reviews Materials, 2019Cherie L Stabler +2 more
exaly
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Nature Reviews Molecular Cell Biology, 2008Christopher B Newgard +2 more
exaly

